Related Experiment Video

Updated: Aug 20, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Cellular pharmacology of anthracycline resistance and its circumvention

H Tapiero, A Fourcade, J N Munck

    Drugs Under Experimental and Clinical Research
    |January 1, 1986
    PubMed

    Insights

    Verapamil, a calcium-channel blocker, enhances the effectiveness of Adriamycin in resistant cancer cells by increasing drug retention. This suggests verapamil may potentiate anticancer drug effects, overcoming multiple drug resistance.

    Area of Science:

    • Pharmacology
    • Cancer Biology
    • Cellular Resistance

    Background:

    • Adriamycin-resistant cells exhibit multidrug resistance (MDR), a phenotype involving decreased drug uptake or retention.
    • Biochemical alterations in cells contribute to this MDR phenotype.
    • Overcoming MDR is crucial for effective cancer chemotherapy.

    Purpose of the Study:

    • To investigate the potential of verapamil, a calcium-channel blocker, in overcoming Adriamycin resistance.
    • To elucidate the mechanism by which verapamil enhances the efficacy of Adriamycin in resistant cells.
    • To determine if verapamil sensitizes or potentiates the effect of anticancer drugs.

    Main Methods:

    • Utilized Adriamycin-resistant cells to model the MDR phenotype.
    • Administered verapamil in combination with Adriamycin.
    • Quantified drug retention and assessed cytotoxic effectiveness.
    • Preliminary analysis of verapamil's mechanism of action.

    Main Results:

    • Verapamil increased the retention of Adriamycin in resistant cells.
    • This enhanced retention led to increased cytotoxic effectiveness of Adriamycin.
    • Preliminary data suggest verapamil potentiates, rather than sensitizes, the action of anticancer drugs.

    Conclusions:

    • Verapamil can enhance the efficacy of Adriamycin in multidrug-resistant cancer cells.
    • The primary mechanism appears to be increased intracellular drug retention.
    • Further research is needed to confirm if verapamil potentiates anticancer drug effects.

    More Related Videos

    Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

    Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

    Published on: December 11, 2017

    Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

    Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

    Published on: June 17, 2022

    Related Concept Videos

    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
    Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
    Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...